Filing Details

Accession Number:
0000899243-22-032050
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-26 21:30:13
Reporting Period:
2022-09-22
Accepted Time:
2022-09-26 21:30:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1799191 Oncology Institute Inc. TOI () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1705748 Havencrest Healthcare Partners, L.p. 2100 Mckinney Ave, Suite 1760
Dallas TX 75201
No No Yes No
1892154 Toi Hc I, Llc 2100 Mckinney Ave, Suite 1760
Dallas TX 75201
No No Yes No
1893722 Havencrest Healthcare Partners Gp, Llc 2100 Mckinney Ave, Suite 1760
Dallas TX 75201
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-09-22 13,086 $4.25 14,700,829 No 4 S Indirect See footnote
Common Stock Disposition 2022-09-23 5,375 $4.19 14,695,454 No 4 S Indirect See footnote
Common Stock Disposition 2022-09-26 7,153 $4.57 14,688,301 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.14 to $4.39, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.02 to $4.30, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.19 to $4.78, inclusive. The reporting person undertakes to provide The Oncology Institute, Inc., any security holder of The Oncology Institute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
  4. TOI HC I, LLC is the record holder of these shares. Havencrest Healthcare Partners, L.P. may be deemed to have beneficial ownership of the shares directly held by TOI HC I, LLC. Havencrest Healthcare Partners GP, LLC controls Havencrest Healthcare Partners, L.P. Each reporting person disclaims beneficial ownership of the reported securities except to the extent of such reporting person's pecuniary interest therein.